Blood test aims to predict breast Cancer's return
NCT ID NCT07136493
Summary
This study is testing a blood test that looks for tiny pieces of leftover cancer DNA after treatment for early-stage breast cancer. The goal is to see if this test can identify patients who still have hidden cancer cells and might benefit from additional therapy. Researchers will follow 350 patients for up to 3 years after their standard surgery and treatment to see if the blood test results predict whether the cancer comes back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE-NEGATIVE BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CTCA at Western Regional Medical Center
Goodyear, Arizona, 85338, United States
-
City of Hope Atlanta Cancer Center
Newnan, Georgia, 30265, United States
-
City of Hope Comprehensive Cancer Center
Duarte, California, 91010, United States
-
City of Hope at Chicago
Zion, Illinois, 60099, United States
-
City of Hope at Irvine Lennar
Irvine, California, 92618, United States
Conditions
Explore the condition pages connected to this study.